In this episode, ‘Strategic Use of ADT in mCSPC From Selection to Escalation,’ the multidisciplinary panelists explore the following questions: With multiple generations of ADT now available in ...

Abstract: In this work, a design approach for array multipliers using approximate adders is presented. Our approach focuses on improving efficiency mainly in terms of resource usage and area. We have ...

In a pooled analysis, longer duration of androgen deprivation therapy (ADT) was associated with nonlinear improvements in outcomes in men with prostate cancer receiving definitive radiotherapy.

Nonlinear improvement seen in relative benefit of distant metastasis, OS, with reduced benefits beyond nine to 12 months of ADT. HealthDay News — Increasing duration of androgen deprivation therapy ...

Patients who received ADT for 3 months or 9 months had worse overall survival than those treated for 36 months. For men with prostate cancer treated with definitive radiotherapy, the benefit derived ...

THURSDAY, Dec. 4, 2025 (HealthDay News) -- Increasing duration of androgen deprivation therapy (ADT) is beneficial for some men with prostate cancer, while those with lower risk cancer may not need ...

(TNS) — As some patrol officers in the Twin Cities are starting to use artificial intelligence for composing their reports, the St. Paul Police Department isn’t yet taking the leap to the cutting-edge ...

Abstract: Because of the parallelism and reprogrammability of these digital devices, the implementation of Artificial Neural Networks (ANNs) using Field Programmable Gate Arrays (FPGAs) has garnered a ...

Metastasis-directed therapy added to ADT helps slow the progression of metastatic prostate cancer, a phase 2 trial finds. The addition of metastasis-directed therapy (MDT) to androgen deprivation ...